278 related articles for article (PubMed ID: 36561716)
21. Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China.
Hu S; Hou Y; Wang Q; Li M; Xu D; Zeng X
Arthritis Res Ther; 2018 Oct; 20(1):235. PubMed ID: 30348207
[TBL] [Abstract][Full Text] [Related]
22. Red blood cell distribution width as a related factor of pulmonary arterial hypertension in patients with systemic sclerosis.
Zhao J; Mo H; Guo X; Wang Q; Xu D; Hou Y; Tian Z; Liu Y; Wang H; Lai J; Li M; Zeng X
Clin Rheumatol; 2018 Apr; 37(4):979-985. PubMed ID: 29164429
[TBL] [Abstract][Full Text] [Related]
23. Interstitial lung disease in South Africans with systemic sclerosis.
Ashmore P; Tikly M; Wong M; Ickinger C
Rheumatol Int; 2018 Apr; 38(4):657-662. PubMed ID: 29185086
[TBL] [Abstract][Full Text] [Related]
24. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and risk factors for left ventricular diastolic dysfunction in a scleroderma cohort.
Vemulapalli S; Cohen L; Hsu V
Scand J Rheumatol; 2017 Jul; 46(4):281-287. PubMed ID: 27635465
[TBL] [Abstract][Full Text] [Related]
26. Clinical Phenotypes of Patients With Systemic Sclerosis With Distinct Molecular Signatures in Skin.
Yang M; Goh V; Lee J; Espinoza M; Yuan Y; Carns M; Aren K; Chung L; Khanna D; McMahan ZH; Agrawal R; Nelson LB; Shah SJ; Whitfield ML; Hinchcliff M
Arthritis Care Res (Hoboken); 2023 Jul; 75(7):1469-1480. PubMed ID: 35997480
[TBL] [Abstract][Full Text] [Related]
27. Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.
Khanna D; Tashkin DP; Denton CP; Renzoni EA; Desai SR; Varga J
Am J Respir Crit Care Med; 2020 Mar; 201(6):650-660. PubMed ID: 31841044
[TBL] [Abstract][Full Text] [Related]
28. Prognostic role of KL-6 in SSc-ILD patients with pleuroparenchymal fibroelastosis.
d'Alessandro M; Bellisai F; Bergantini L; Cameli P; D'Alessandro R; Mazzei MA; Gentili F; Conticini E; Selvi E; Frediani B; Matucci-Cerinic M; Bargagli E
Eur J Clin Invest; 2021 Aug; 51(8):e13543. PubMed ID: 33759179
[TBL] [Abstract][Full Text] [Related]
29. The association between the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio and systemic sclerosis and its complications: a systematic review and meta-analysis.
Zinellu A; Mangoni AA
Front Immunol; 2024; 15():1395993. PubMed ID: 38799443
[TBL] [Abstract][Full Text] [Related]
30. Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease.
Elhai M; Hoffmann-Vold AM; Avouac J; Pezet S; Cauvet A; Leblond A; Fretheim H; Garen T; Kuwana M; Molberg Ø; Allanore Y
Arthritis Rheumatol; 2019 Jun; 71(6):972-982. PubMed ID: 30624031
[TBL] [Abstract][Full Text] [Related]
31. Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: A retrospective cohort study.
Vandecasteele E; Melsens K; Vanhaecke A; Blockmans D; Bonroy C; Carton C; Deschepper E; De Keyser F; Houssiau F; Piette Y; Vanthuyne M; Verbeke K; Westhovens R; Wuyts WA; De Langhe E; Brusselle G; Smith V
Semin Arthritis Rheum; 2021 Oct; 51(5):969-976. PubMed ID: 34403812
[TBL] [Abstract][Full Text] [Related]
32. Determinants of morbidity and mortality of systemic sclerosis in Canada.
Al-Dhaher FF; Pope JE; Ouimet JM
Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
[TBL] [Abstract][Full Text] [Related]
33. Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort.
Noviani M; Saffari SE; Tan JL; Yip JWL; Teng GG; Law WG; Chan GYL; Santosa A; Lim AYN; Hong C; Ng SA; Tay ELW; Ruan W; Yap J; Low AHL
Semin Arthritis Rheum; 2020 Jun; 50(3):473-479. PubMed ID: 31810742
[TBL] [Abstract][Full Text] [Related]
34. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
[TBL] [Abstract][Full Text] [Related]
35. Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis.
Campochiaro C; Hoffmann-Vold AM; Avouac J; Henes J; de Vries-Bouwstra J; Smith V; Siegert E; Airò P; Oksel F; Pellerito R; Vanthuyne M; Pozzi MR; Inanc M; Sibilia J; Gabrielli A; Distler O; Allanore Y;
Rheumatology (Oxford); 2023 Jul; 62(7):2483-2491. PubMed ID: 36413079
[TBL] [Abstract][Full Text] [Related]
36. [Expression and clinical significance of plasma exosomal miR-34-5p and miR-142-3p in systemic sclerosis].
Li WG; Gu XD; Weng RQ; Liu SD; Chen C
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1022-1027. PubMed ID: 38101783
[TBL] [Abstract][Full Text] [Related]
37. Serum KL-6 and surfactant protein-D as monitoring and predictive markers of interstitial lung disease in patients with systemic sclerosis and mixed connective tissue disease.
Yamakawa H; Hagiwara E; Kitamura H; Yamanaka Y; Ikeda S; Sekine A; Baba T; Okudela K; Iwasawa T; Takemura T; Kuwano K; Ogura T
J Thorac Dis; 2017 Feb; 9(2):362-371. PubMed ID: 28275485
[TBL] [Abstract][Full Text] [Related]
38. [Sex disparities in clinical characteristics of Chinese patients with systemic sclerosis].
Hou YY; Duan XW; Li Q; Li HB; Zhou JX; Hou Y; Li MT; Zhao JL; Wang Q; Xu D; Zeng X
Zhonghua Nei Ke Za Zhi; 2022 Apr; 61(4):403-408. PubMed ID: 35340187
[No Abstract] [Full Text] [Related]
39. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary arterial hypertension and systemic sclerosis relation: a single centre experience.
Demir N; Şahin A; Küçükşahin O; Kayacan O; Dinçer İ; Sayın T; Karnak D; Turgay M
Heart Lung Circ; 2014 Jul; 23(7):667-73. PubMed ID: 24613044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
